Sarepta Therapeutics (SRPT) Restructuring Costs (2025)
Sarepta Therapeutics (SRPT) recorded quarterly Restructuring Costs of $1.5 million in Q4 2025, down 96.3% quarter-over-quarter from $40.5 million in Q3 2025.
Sarepta Therapeutics (SRPT) Restructuring Costs (2025) Analysis & Trends
Sarepta Therapeutics' Restructuring Costs history runs 1 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- In Q4 2025, Restructuring Costs changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $42.0 million (changed N/A YoY), while the FY2025 annual figure was $42.0 million, changed N/A from the prior year.
- Restructuring Costs was $1.5 million for Q4 2025 at Sarepta Therapeutics, down from $40.5 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $40.5 million in Q3 2025 to a low of $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 40.50 Mn |